Analysis of the influence of drug resistance factors on the efficacy of combinations of antibiotics for multidrug-resistant Pseudomonas aeruginosa isolated from hospitals located in the suburbs of Kanto area, Japan

Journal of Global Antimicrobial Resistance - Tập 1 - Trang 91-96 - 2013
Hiroshi Kataoka1, Takashi Ida1, Yoshikazu Ishii2, Kazuhiro Tateda2, Toyoko Oguri3, Atsushi Yoshida4, Katsuko Okuzumi4, Tsuyoshi Oishi5, Miyuki Tsukahara5, Shin-ichiro Mori6, Akiko Yoneyama7, Hideki Araoka7, Toshihiro Mitsuda8, Midori Sumitomo8, Kyoji Moriya9, Mieko Goto9, Yoshitaka Nakamori10, Akiyoshi Shibayama10, Norio Ohmagari11, Tomoaki Sato11
1Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., Tokyo 104 8002, Japan
2Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, Tokyo 143 8540, Japan
3Kameda General Hospital, Chiba 296-8602, Japan
4Dokkyo Medical University Hospital, Tochigi 321 0293, Japan
5Tokyo Medical University Ibaraki Medical Center, Ibaraki 300 0395, Japan
6National Cancer Center Hospital, Tokyo 104 0045, Japan
7Department of Infectious Diseases, Toranomon Hospital, Tokyo 105 8470, Japan
8Yokohama City University Hospital, Kanagawa 236 0004, Japan
9Graduate School of Medicine, The University of Tokyo, Tokyo 113 8655, Japan
10Department of Respiratory Diseases, Misyuku Hospital, Tokyo 153 051, Japan
11Shizuoka Cancer Center, Shizuoka 411 8777, Japan

Tài liệu tham khảo

Mesaros, 2007, Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium, Clinical Microbiology and Infection, 13, 560, 10.1111/j.1469-0691.2007.01681.x Kirikae, 2008, Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan, Journal of Antimicrobial Chemotherapy, 61, 612, 10.1093/jac/dkm537 Aoki, 2009, Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa, Journal of Antimicrobial Chemotherapy, 63, 534, 10.1093/jac/dkn530 Erdem, 2003, In vitro activity of combination therapy with cefepime, piperacillin–tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains, Chemotherapy, 49, 294, 10.1159/000074529 Giamarellou, 1986, Aminoglycoside plus β-lactams against Gram-negative organisms. Evaluation of in vitro synergy and chemical interactions, American Journal of Medicine, 80, 126, 10.1016/0002-9343(86)90490-0 Louie, 2010, The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression, Antimicrobial Agents and Chemotherapy, 54, 2646, 10.1128/AAC.00065-10 Song, 2003, In vitro activity of β-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa, International Journal of Antimicrobial Agents, 21, 8, 10.1016/S0924-8579(02)00269-8 Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009. Sanbongi, 2009, Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan, Microbiology and Immunology, 53, 361, 10.1111/j.1348-0421.2009.00137.x Shibata, 2003, PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by Gram-negative bacteria isolated in Japan, with focus on the class 3 integron, Journal of Clinical Microbiology, 41, 5407, 10.1128/JCM.41.12.5407-5413.2003 Jalal, 1998, Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa, Microbial Drug Resistance, 4, 257, 10.1089/mdr.1998.4.257 Vos, 1995, AFLP: a new technique for DNA fingerprinting, Nucleic Acids Research, 23, 4407, 10.1093/nar/23.21.4407 Tateda, 2006, ‘Break-point Checkerboard Plate’ for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa, Scandinavian Journal of Infectious Diseases, 38, 268, 10.1080/00365540500440353 Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Document M100-S22. Wayne, PA: CLSI; 2012. Watanabe, 1991, Transferable imipenem resistance in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, 35, 147, 10.1128/AAC.35.1.147 Sekiguchi, 2007, Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan, Journal of Clinical Microbiology, 45, 979, 10.1128/JCM.01772-06 Laraki, 1999, Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli, Antimicrobial Agents and Chemotherapy, 43, 902, 10.1128/AAC.43.4.902 Pool, 2005, Aminoglycoside resistance in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, 49, 479, 10.1128/AAC.49.2.479-487.2005 Araoka, 2010, Monobactam and aminoglycoside combination therapy against metallo-β-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a ‘break-point checkerboard plate’, Scandinavian Journal of Infectious Diseases, 42, 231, 10.3109/00365540903443157 Sekiguchi, 2005, Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6′)-Iae gene cassette encoding a novel aminoglycoside acetyltransferase, Antimicrobial Agents and Chemotherapy, 49, 3734, 10.1128/AAC.49.9.3734-3742.2005 Yamane, 2007, 16S rRNA methylase-producing, Gram-negative pathogens, Japan, Emerging Infectious Diseases, 13, 642, 10.3201/eid1304.060501 Giamarellos-Bourboulis, 2003, In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa, Journal of Chemotherapy, 15, 235, 10.1179/joc.2003.15.3.235